News

Health

What the evidence actually shows — drugs, procedures, and studies, read closely and reported straight.

GLP-1 Use Hits 11 Percent of U.S. Adults, Gallup Finds. Cost Drove Most of the Switch to Compounded Versions.

Gallup's new poll puts current GLP-1 use at 11 percent of U.S. adults, up from 3 percent in 2024, and finds cost drove most switches to compounded versions.

The News Desk · 4 min read

Small glass medication vials, a green plastic syringe, a white pill bottle, and an injection pen arranged on a wooden side table.

News

Cigna Stopped Covering Its Own Employees' Weight-Loss Drugs in July. Starbucks Follows in October.

The News Desk · 8 min read

A hand holding a blue marker circling the number 7 on a plain printed month calendar, with a small white glucose meter and a lancing device lying beside it on a lavender background.

News

Two Years After Stopping GLP-1s, Epic Says Most Patients Held. It Calculated "Stopping" From Refills.

The News Desk · 7 min read

A close-up of a semaglutide injection pen lying on a pale surface beside its blue cap, the dose window and plunger visible along the barrel and the drug name printed on the side.

News

The Muscle Warning About GLP-1s Leaves Out What the Placebo Group Did

The News Desk · 4 min read

Health

GLP-1 Use Hits 11 Percent of U.S. Adults, Gallup Finds. Cost Drove Most of the Switch to Compounded Versions.

Cigna Stopped Covering Its Own Employees' Weight-Loss Drugs in July. Starbucks Follows in October.

Two Years After Stopping GLP-1s, Epic Says Most Patients Held. It Calculated "Stopping" From Refills.

The Muscle Warning About GLP-1s Leaves Out What the Placebo Group Did

Never miss an issue